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the VMH, which provides a molecular
basis for the regulation of energy
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AMP-activated protein kinase (AMPK) in the ventro-
medial nucleus of the hypothalamus (VMH) and
orexin (OX) in the lateral hypothalamic area (LHA)
modulate brown adipose tissue (BAT) thermogene-
sis. However, whether these two molecular mecha-
nisms act jointly or independently is unclear. Here,
we show that the thermogenic effect of bone
morphogenetic protein 8B (BMP8B) is mediated by
the inhibition of AMPK in the VMH and the subse-
quent increase in OX signaling via the OX receptor
1 (OX1R). Accordingly, the thermogenic effect of
BMP8B is totally absent in ox-null mice. BMP8B
also induces browning of white adipose tissue
(WAT), its thermogenic effect is sexually dimorphic
(only observed in females), and its impact on OX
expression and thermogenesis is abolished by the
knockdown of glutamate vesicular transporter 2
(VGLUT2), implicating glutamatergic signaling. Over-
all, our data uncover a central network controlling
energy homeostasis that may be of considerable
relevance for obesity and metabolic disorders.
INTRODUCTION
Hypothalamic neural circuits are involved in the control of a large
number of functions, the regulation of endocrine axes and energy
balance being of particular importance (Yeo and Heisler, 2012;
Schneeberger et al., 2014; Lo´pez et al., 2016). Substantial interest
and efforts have been devoted to the analysis of the arcuate nu-
cleus of the hypothalamus (ARC), which, in fact, has been consid-Cell Re
This is an open access article under the CC BY-Nered as the master hypothalamic center for energy homeostasis
(Yeo and Heisler, 2012; Schneeberger et al., 2014; Lo´pez et al.,
2016). Despite this evidence, other hypothalamic sites, such as
the ventromedial nucleus of the hypothalamus (VMH), formerly
characterized as the brain satiety center, and the lateral hypotha-
lamic area (LHA), formerly characterized as the brain hunger cen-
ter (Hecherington and Ranson, 1942; Anand and Brobeck, 1951),
also play major and probably more integrative roles than the ARC
in the modulation of energy balance. These regions receive infor-
mation fromARCneurons and also project their axons to other hy-
pothalamic and extra-hypothalamic sites (Schneeberger et al.,
2014; Contreras et al., 2015; Lo´pez et al., 2016) to control not
only feeding but also several peripheral processes, such as adi-
pose and hepatic metabolism, as well as brown adipose tissue
(BAT) thermogenesis through the sympathetic (SNS) and para-
sympathetic nervous system (PSNS) (Nogueiras et al., 2007;
Fliers et al., 2010; Stanley et al., 2010; Imbernon et al., 2013; Lo´-
pez et al., 2013, 2016).
The molecular mediators within those areas have begun to be
characterized, and over the last 5 years extensive attention has
been focused on the role of AMP-activated protein kinase
(AMPK) in the VMH and orexin (OX) in the LHA as key modulators
of brown fat. Thus, inhibition of AMPK function in the VMH (Lo´pez
et al., 2010b, 2016; Martı´nez de Morentin et al., 2012, 2014;
Whittle et al., 2012; Tanida et al., 2013; Beiroa et al., 2014) or
increased orexigenic tone in the LHA (Teske et al., 2006; Tupone
et al., 2011; Morrison et al., 2012; Madden et al., 2012) activates
the BAT thermogenic program, leading to elevated temperature,
increased energy expenditure (EE), and weight loss. In addition,
OX neurons in the LHA are required for BAT development and
differentiation (Sellayah et al., 2011; Sellayah and Sikder, 2012,
2014). In spite of this evidence, no functional data have linked
those neuronal populations, and it is currently unknown whether
AMPK in the VMH and OX neurons in the LHA are part of theports 16, 2231–2242, August 23, 2016 ª 2016 The Author(s). 2231
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
same circuit modulating BAT function or, alternatively, they func-
tion separately.
Bone morphogenetic proteins (BMPs) belong to the trans-
forming growth factor b (TGF-b) superfamily. BMPs regulate a
wide range of processes from embryonic development to tissue
homeostasis (Schulz and Tseng, 2009; Modica and Wolfrum,
2013). Among these functions, BMPs also are involved in adipo-
cyte development. BMP2 and -4 and BMP7 and -9 were identi-
fied as important elements in white and brown adipocyte differ-
entiation, respectively (Tang et al., 2004; Bowers et al., 2006;
Huang et al., 2009; Kuo et al., 2014). In addition, a more recent
report has shown that BMP4 induces brown adipocyte charac-
teristics in mature white adipocytes (Qian et al., 2013). Other
recent findings, including those from our group, surfaced a role
for BMPs in energy balance. Thus, BMP7 and BMP8B were
demonstrated to regulate BAT thermogenic function and in-
crease EE (Tseng et al., 2008; Townsend et al., 2012, 2013;
Whittle et al., 2012). Given that BMP8B acts centrally, its thermo-
genic effect is dependent upon the activation status of AMPK in
the VMH, and it increases neuronal activation in the LHA (Whittle
et al., 2012), we aimed to uncover the neuronal circuitry linking
energy sensors and neuropeptides involved in the thermogenic
effect of central BMP8B.
RESULTS
The Thermogenic Effect of Central BMP8B Is Sexually
Dimorphic
Recent evidence has demonstrated that central BMP8B exerts a
robust thermogenic effect in females (Whittle et al., 2012). Thus,
we aimed to investigate whether males had a similar response.
Our data showed that after 2 hr of an intracerebroventricular
(i.c.v.) injection of BMP8B, male rats did not show an increase
in either body (Figure 1A) or BAT temperature (Figure 1B).
Next we analyzed the effect of central BMP8B in ovariecto-
mized (OVX) female rats with and without estradiol (E2) replace-
ment and their sham-operated controls (Martı´nez de Morentin
et al., 2014, 2015). OVX rats gained significantly more weight
(sham: 23.1 ± 2.38 g versus OVX: 71.3 ± 28 g; p < 0.001) and
developed a marked hyperphagia (sham: 14.87 ± 0.31 g/day
versus OVX: 17.70 ± 0.49 g/day; p < 0.01), confirming the effi-
ciency of the OVX procedure. While central administration of
BMP8B to sham controls induced a clear thermogenic action,
OVX totally abolished it at both body and BAT temperature levels.
Of note, OVX rats with E2 replacement responded normally to
BMP8B (Figures 1C and 1D). Overall, these data indicated that
the thermogenic action of BMP8B shows a sexual dimorphism
and depends on physiological levels of ovarian estrogens.
The Thermogenic Effect of Central BMP8B Is
Independent of Environmental Temperature
We aimed to investigate whether the thermogenic central ac-
tions of BMP8B were affected by temperature. Therefore, we
administered central BMP8B to female rats kept at 23C or
4C during 10 hr prior to the i.c.v. treatment and for a total of
12 hr. Our data showed that BMP8B protected against the loss
of both core (Figure 1E) and BAT (Figure 1F) temperature when
given at 4C.2232 Cell Reports 16, 2231–2242, August 23, 2016BMP8B in the VMH, but Not in the LHA, Induces Negative
Energy Balance
To investigate the effect of chronic nucleus-specific BMP8B
treatment, stereotaxic cannulae were placed in the VMH and
the LHA. The correct position of the cannulae was verified by his-
tological examination of coronal sections of the brains (Figures
S1A and S1B). Noteworthy, the expression of BMP type I recep-
tors ALK4, ALK5, and ALK7 in those nuclei was demonstrated
by real-time RT-PCR analysis (Figure S2A) of dissected VMH
and LHA, whose specificity was controlled by analysis of the
specific markers steroidogenic factor 1 (SF1) and OX, respec-
tively (Figure S2B).
When given in the VMH, BMP8B promoted a feeding-inde-
pendent weight loss (Figure 2A; initial body weight vehicle
VMH: 240.0 ± 4.4 g versus BMP8B VMH: 237.5 ± 4.0 g; non-
significant); no effect was observedwhenBMP8Bwas injected in
the LHA (Figure 2B; initial body weight vehicle LHA: 233.0 ± 3.1 g
versus BMP8B LHA: 235.1 ± 1.8 g; non-significant). The action of
BMP8B in the VMH was associated with a trend (p = 0.07) to
reduce adiposity without changes in the lean mass (Figure 2C).
BMP8B in the LHA promoted no changes either in fat or lean
mass (Figure 2D).
BMP8B in the VMH, but Not in the LHA, Increases
Temperature and EE
Treatment with BMP8B within the VMH induced a marked eleva-
tion in body temperature, which was consistent during the whole
period of administration (Figure 2E). No effect on body tempera-
ture was found when BMP8B was given in the LHA (Figure 2F).
Moreover, BMP8B in the VMH, but not in the LHA, increased EE
(Figures2Gand2H) and reduced the respiratoryquotient (RQ;Fig-
ures 2I and 2J). No changes in locomotor activity (LA) were found
whenBMP8Bwas administered either in the VMHor the LHA (Fig-
ures 2K and 2L), although a non-significant trend (p = 0.07) for
increased LA was detected in VMH BMP8B-treated rats.
BMP8B in the VMH, but Not in the LHA, Regulates
Hypothalamic AMPK, the Expression of Thermogenic
Markers in BAT, and Browning of WAT
We aimed to investigate whether hypothalamic nucleus-specific
BMP8B actions result in changes in AMPK signaling within the
VMH. We found that VMH administration of BMP8B decreased
the phosphorylated levels of AMPKa (pAMPKa) and its down-
stream target acetyl-CoA carboxylase alpha (pACCa); no
changes were found in total levels of AMPKa1, AMPKa2, ACCa,
and fatty acid synthase (FAS) (Figure 3A). BMP8B within the
VMH also increased UCP1 protein levels (Figure 3B) and the
mRNA expression of thermogenic markers (Figure 3C) in the
brown fat. When administered in the LHA, BMP8B did not affect
either AMPK signaling in the VMH (Figure 3D) or UCP1 protein
levels (Figure 3E) or the mRNA expression of thermogenic
markers (Figure 3F) in the BAT. This evidence suggests that
BMP8B’s actions on the VMH are direct and not mediated by a
previous effect on the LHA.
In relation to the white adipose tissue (WAT), our mRNA data
showed that browning markers had a tendency to be increased
in the WAT of rats receiving BMP8B in the VMH, but not in the
LHA (Figures 3G and 3I). Histological analysis of WAT showed
Figure 1. Effect of i.c.v. Administration of BMP8B on Energy Balance
(A and B) Body temperature change (A) and thermal images (B, left panel) and quantification of temperature change in the skin surrounding BAT (right
panel) of female andmale rats receiving i.c.v. administration of BMP8B or vehicle. Experimentswere repeated twice and total animals per experimental groupwas
n = 6–18.
(C and D) Body temperature change (C) and thermal images (D, left panel) and quantification of temperature change in the skin surrounding BAT (right panel) of
sham and OVX with and without E2 replacement rats receiving i.c.v. administration of BMP8B or vehicle. Experiments were repeated twice and total animals per
experimental group was n = 12–15.
(E and F) Body temperature change (E) and thermal images (F, left panel) and quantification of temperature change in the skin surrounding BAT (right panel) of
female rats exposed to 23C or 4C during 12 hr and receiving i.c.v. administration of BMP8B or vehicle. Experiments were repeated twice and total animals per
experimental group was n = 10–16. For each set of data a representative experiment is shown. Data are expressed as mean ± SEM (*p < 0.05, **p < 0.01, and
***p < 0.001 versus vehicle [female vehicle and sham vehicle]; &p < 0.05 and &&p < 0.01 versus OVX vehicle; and ##p < 0.01 and ###p < 0.001 versus OVX
BMP8B). Temperature changes were calculated versus basal values.that BMP8B-treated rats in the VMH displayed a brown-like
pattern, associated with increased UCP1 immunostaining and
decreased adipocyte area (Figure 3H). No changes were found
when BMP8B was given in the LHA (Figure 3J). Overall, these
data indicated that the effects of BMP8B on browning are spe-
cific for the VMH.Central BMP8B Increases OX Expression in the LHA
through AMPK in the VMH
Recent data have demonstrated a key role for OX onBAT thermo-
genic activity (Tupone et al., 2011; Sellayah et al., 2011; Morrison
et al., 2012;Maddenet al., 2012;SellayahandSikder, 2012, 2014).
Furthermore, it has been reported that central administration ofCell Reports 16, 2231–2242, August 23, 2016 2233
Figure 2. Effect of Stereotaxic Administration of BMP8B on Energy Balance
(A–L) The following are shown: (A and B) daily food intake (left panel) and body weight change (right panel), (C and D) fat mass (left panel) and lean mass (right
panel), (E and F) body temperature change, (G and H) energy expenditure (EE; left panel cumulative, right panel total), (I and J) respiratory quotient (RQ), and (K
and L) locomotor activity (LA; left panel cumulative, right panel total) of rats receiving chronic stereotaxic administration of vehicle or BMP8B in the VMH (A, C, E,
G, I, and K) or the LHA (B, D, F, H, J, and L). Data are expressed asmean ± SEM (n = 8–16 animals per experimental group; *p < 0.05 and **p < 0.01 versus vehicle
VMH). Temperature changes were calculated versus basal values.BMP8Bincreasedneuronal activity in theLHA (Whittleetal., 2012),
themain hypothalamic area expressingOX. Thus, we investigated
the possible effect of BMP8B on OX expression in the LHA. Our
data showed that i.c.v. administration of BMP8B increased body
temperature (vehicle i.c.v.: 0.1C ± 0.09C versus BMP8B
i.c.v.: 0.48C ± 0.07C; p < 0.001) and UCP1 protein levels in
BAT (vehicle i.c.v.: 100% ± 14.6% versus BMP8B i.c.v.: 137.8%
± 10.1%; p< 0.05), in associationwith elevatedOXmRNAexpres-
sion in the LHA (Figure S3A).
To gain further insight into BMP8B effects on OX expression,
we analyzed the effect of specific administration of BMP8B
in the VMH. Our data showed that, when given in that
nucleus, BMP8B also increased the mRNA levels of OX in
the LHA (Figure 4A). These results suggested that BMP8B in
the VMH acts upstream in the LHA to promote OX expression.
To elucidate the contribution of AMPK activity in the VMH to
the thermogenic effect of BMP8B, adenoviruses encoding
constitutively active AMPKa (AMPKa-CA) together with GFP or
control adenovirus expressing GFP alone (Lo´pez et al., 2010b;
Whittle et al., 2012; Martı´nez de Morentin et al., 2012, 2014;2234 Cell Reports 16, 2231–2242, August 23, 2016Beiroa et al., 2014) were injected stereotaxically into the VMH
of rats centrally treated with vehicle or BMP8B. Infection
efficiency was assessed by the expression of GFP in the VMH
(Figure 4B). The administration of AMPKa-CA adenoviruses
alone did not have any impact either in body temperature
change (vehicle GFP: 0.37C ± 0.14C versus vehicle AMP-
Ka-CA: 0.3C ± 0.11C, non-significant) or BAT temperature
(vehicle GFP: 0.35C ± 0.21C versus vehicle AMPKa-CA:
0.29C ± 0.15C, non-significant). When given to BMP8B-
treated rats, constitutive activation of AMPK in the VMH reversed
the thermogenic effect of BMP8B at both whole body (Figure 4C)
andBAT levels (Figure 4D). This effect alsowas associatedwith a
reduction in the expression of OX in the LHA (Figure 4E). These
results suggest that central BMP8B action on OX expression is
mediated by the inhibition of AMPK in the VMH.
OX1R Antagonism Reversed the Thermogenic Effect of
Central BMP8B
It has been reported recently that OX1R mediates OX actions
on BAT function (Sellayah and Sikder, 2012). Thus, rats
Figure 3. Effect of Stereotaxic Administration of BMP8B on Hypothalamic AMPK, BAT UCP1, and Browning of WAT
(A–J) The following are shown: (A and D) western blot images (left panel) and protein levels of the AMPK pathway (right panel); (B and E) western blot images (left
panel) and UCP1 protein levels in BAT (right panel); (C and F) mRNA expression of thermogenic markers in BAT; (G and I) mRNA expression of browning markers
in WAT; and (H and J) microphotographs of WAT showing UCP1 immunostaining (left panel), quantification of UCP1 staining (middle panel), and adipocyte area
(right panel) of rats receiving chronic stereotaxic administration of vehicle or BMP8B in the VMH (A–C, G, and H) or the LHA (D–F, I, and J). Data are expressed as
mean ± SEM (n = 8–9 animals per experimental group; *p < 0.05, **p < 0.01, and ***p < 0.001 versus vehicle VMH).received the OX1R antagonist SB-334867 (Jia et al., 2012)
30 min prior to BMP8B administration. SB-334867 alone had
no effect on body temperature at any examined time (2 hr
vehicle vehicle: 0.19C ± 0.08C versus vehicle SB-334867:
0.20 ± 0.07, non-significant; 4 hr vehicle vehicle: 0.40C ±
0.14C versus vehicle SB-334867: 0.39 ± 0.17, non-significant;
and 6 hr vehicle vehicle: 0.26C ± 0.13C versus vehicle SB-
334867: 0.23 ± 0.19, non-significant). However, SB-334867significantly blunted the thermogenic effect of BMP8B at 4
and 6 hr after BMP8B treatment but only partially at 2 hr (Fig-
ure 4F), probably due to early effects independent of OX1R or
a delayed effect of the antagonist. Of note, SB-334867 did not
have any impact on the BMP8B-induced decrease in AMPK
signaling in the VMH (Figure 4G), suggesting that AMPK in
that nucleus operates upstream of OX1R signaling in this
pathway.Cell Reports 16, 2231–2242, August 23, 2016 2235
Figure 4. Effect of BMP8B in the VMH on OX System
(A) In situ hybridization images (left panel) and OXmRNA levels in the LHA (right panel) of rats receiving chronic stereotaxic administration of BMP8B or vehicle in
the VMH are shown.
(B) Representative immunofluorescence (203) with anti-GFP antibody showing GFP expression in the VMH of rats treated with adenoviruses within the VMH, is
shown.
(C–E) The (C) quantification of body temperature change, (D) thermal images (left panel) and quantification of temperature change in the skin surrounding BAT
(right panel), and (E) in situ hybridization images (left panel) and OX mRNA levels in the LHA (right panel) of rats i.c.v. treated with vehicle or BMP8B and ste-
reotaxically treated with GFP or AMPKa-CA adenoviruses within the VMH are shown.
(F and G) The (F) body temperature change and (G) western blot images (left panel) and protein levels of the AMPK pathway (right panel) of rats i.c.v. treated with
vehicle or BMP8B and i.c.v. treatment with theOX1R antagonist SB-334867. Data are expressed asmean ±SEM (n = 8–12 animals per experimental group for the
AMPKa-CA experiments, n = 30–40 animals per experimental group for the temperature analysis, and n = 8 animals per experimental group for the western blot
analysis for the SB-334867 experiments; *p < 0.05, **p < 0.01, and ***p < 0.001 versus vehicle VMH, vehicle GFP, or vehicle vehicle; #p < 0.05 and ##p < 0.01
versus BMP8B GFP or BMP8B vehicle). Temperature changes were calculated versus basal values. 3V, third ventricle; ME, median eminence.
2236 Cell Reports 16, 2231–2242, August 23, 2016
Figure 5. Effect of OX Deficiency on BMP8B Action
(A–D) The (A) body temperature change, (B) thermal images (left panel) and quantification of temperature change of the skin surrounding BAT (right panel), and (C
and D) western blot images (left panel) and VMH protein levels of the AMPK pathway (right panel) of Ox-null mice (OX KO) and their WT littermates, i.c.v. treated
with vehicle or BMP8B. Data are expressed as mean ± SEM (n = 11–13 animals per experimental group; *p < 0.05 and **p < 0.01 versus vehicle). Temperature
changes were calculated versus basal values.OX Mediates the Thermogenic Effect of Central BMP8B
Independently of Environmental Temperature
Afterward, we examined the effect of BMP8B on Ox-null mice
and their wild-type (WT) littermates. When given centrally,
BMP8B increased body temperature (Figure 5A) and BAT tem-
perature (Figure 5B) in WT, but not in OX knockout (KO) mice.
Notably, AMPK signaling was decreased in the VMH of both
WT (Figure 5C) and OX KO mice (Figure 5D), suggesting again
that AMPK in the VMH is upstream of OX in the LHA.
We also investigated whether the effect of OX on BMP8B-
induced thermogenesis was dependent on temperature. Our
data showed that null mice were cold intolerant when exposed
to 4C for just 12 hr (Figure 6A). Next we analyzed the effect of
i.c.v. BMP8B on WT and OX KO animals at 23C and 4C. Our
data demonstrated that, while WT mice kept at 4C had a full
thermogenic response to central BMP8B (similarly to rats; Fig-
ures 1E and 1F), OX KO mice failed to respond (Figures 6B and
6C). Those effects were associated with a similar effect in the
VMH in both genotypes, i.e., reduced pAMPK levels, after the
i.c.v. injection of BMP8B (Figures 6D and 6E). However, accord-
ingly with the temperature data, while WT mice displayed
elevated UCP1 protein levels in BAT (Figure 6F), KO mice did
not (Figure 6G). Again, these data reinforced the ideas that the
VMH-LHA circuit is essential for the central actions of BMP8B
on BAT and that OX acts downstream of AMPK in the VMH.
Glutamatergic Signaling Mediates the Thermogenic
Effect of Central BMP8B
Finally, we aimed to investigate the cellular mechanism through
which BMP8B mediates increased OX expression in the LHA. Itis known that glutamate and glutamate transporters, particular-
ity glutamate vesicular transporter 2 (VGLUT2), play a main role
in hypothalamic regulation of energy balance (Tong et al.,
2007). Therefore, we investigated whether virogenetic targeting
of VGLUT2 within the LHA, by using lentiviruses harboring a
small hairpin RNA (shRNA) against VGLUT2 (or their GFP con-
trols), might reverse the effects of BMP8B on OX expression.
Infection efficiency was assessed by decreased VGLUT2 levels
in that area (Figure 7A). Our data showed that shVGLUT2
lentiviruses totally blunted central BMP8B effects on both
core and BAT temperatures (Figures 7B and 7C). Those func-
tional readouts were associated with a normalization in the
BMP8B-induced increase in OX mRNA levels in the LHA (Fig-
ure 7D) and UCP1 protein concentration in the BAT (Figures
7E and 7F). Of note, pAMPK protein levels were reduced in
both the GFP- and the shVGLUT2-treated groups (vehicle
GFP: 100 ± 18.6 versus BMP8B GFP: 42.6 ± 12.3, p < 0.05;
and vehicle shVGLUT2: 100 ± 10.7 versus BMP8B shVGLUT2:
62.9 ± 12.5, p < 0.05), indicating that glutamatergic signaling
was acting downstream of AMPK.
DISCUSSION
Here, we report a functional link between AMPK in the VMH and
OX neurons in the LHA.Moreover, we show that the thermogenic
effect of BMP8B is mediated by the inhibition of AMPK in the
VMH, the glutamatergic signaling in the LHA, and the subse-
quent increase in OX signaling through OX1R.
BAT is a specialized tissue responsible for heat produc-
tion through non-shivering thermogenesis (NST) (Cannon andCell Reports 16, 2231–2242, August 23, 2016 2237
Figure 6. Effect of OX Deficiency and Cold on BMP8B Action
(A) Body temperatures of Ox-null mice (OX KO) and their WT littermates exposed to 23C or 4C are shown.
(B–G) The (B) body temperature change, (C) thermal images (left panel) and quantification of temperature change of the skin surrounding BAT (right panel), (D and
E) western blot images (left panel) and VMH pAMPKa protein levels (right panel), and (F and G) western blot images (left panel) and BAT UCP1 protein levels (right
panel) of Ox-null mice (OX KO) (B, C, E, and G) and their WT littermates (B–D and F) i.c.v. treated with vehicle or BMP8B and exposed to cold for 12 hr. Data are
expressed as mean ± SEM (n = 6–12 animals per experimental group; *p < 0.05, **p < 0.01, and ***p < 0.001 versus vehicle; ###p < 0.001 versus KO 23C; and
&p < 0.05 versus WT 4C). Temperature changes were calculated versus basal values.Nedergaard, 2004; Morrison et al., 2014; Contreras et al., 2015).
Until recently, BAT was considered to be important only in small
or hibernating mammals and in newborn humans. Recent
studies have challenged that view by using positron emission to-
mography-computed tomography (PET-CT) scans to identify
functional BAT in adult humans (Nedergaard et al., 2007; Cypess
et al., 2009; Virtanen et al., 2009; van Marken Lichtenbelt et al.,
2009), and brown fat is now considered as a potential target or-
gan in the treatment of obesity (Villarroya and Vidal-Puig, 2013;
Contreras et al., 2015). The CNS controls BAT function through
the SNS. BAT is activated by increased firing of the sympathetic
nerves, leading to the release of noradrenaline and activation on
b3-adrenergic receptors (Cannon and Nedergaard, 2004; Con-
treras et al., 2015; Lo´pez et al., 2016).
Recent data have demonstrated that central BMP8B elicits
BAT thermogenesis in females through modulation of hypotha-
lamic AMPK (Whittle et al., 2012). Of note, this mechanism is
shared by E2, which also displays a potent central thermogenic
action (Martı´nez de Morentin et al., 2014, 2015). Here we show
that male rats did not respond to central BMP8B administration,
which might indicate dependence on ovarian steroids, a possi-
bility that was further confirmed by using OVX rats with and
without E2 replacement. This is of relevance because it indicates
that BMP8B actions are sexually dimorphic. In this sense, it has2238 Cell Reports 16, 2231–2242, August 23, 2016been reported that BMP8B expression in BAT is regulated by es-
trogens (Grefhorst et al., 2015). Further work analyzing E2 effects
in BMP8B KO mice (Whittle et al., 2012) will help to clarify this
issue.
Within the hypothalamus, the VMH was the first hypothalamic
site to be identified as important in BAT thermogenic action (Per-
kins et al., 1981). Anatomical data also have demonstrated that
VMH neurons project to autonomic centers in the hypothalamus
and the hindbrain linked to the regulation of BAT (Lindberg et al.,
2013). Recent evidence has revealed that particular sets of cells
within the VMH, such as SF1 neurons (Kim et al., 2011; Xu et al.,
2011), and specific energy sensors, such as AMPK (Lo´pez et al.,
2010b, 2016; Martı´nez de Morentin et al., 2012, 2014; Whittle
et al., 2012; Tanida et al., 2013; Beiroa et al., 2014), control the
sympathetic firing on BAT to regulate thermogenesis and brown-
ing ofWAT (Beiroa et al., 2014). The LHA, containingOX neurons,
also is involved in thermoregulation and EE. Activation of the LHA
promotes BAT function (Cerri and Morrison, 2005), and compel-
ling evidence has shown that this effect is mediated byOX acting
on OX1R and involving direct projections from the LHA to the
raphe pallidus (RPa), a key area modulating the sympathetic
tone to brown fat (Yasuda et al., 2005; Sellayah et al., 2011; Tu-
pone et al., 2011; Madden et al., 2012; Sellayah and Sikder,
2012, 2014).
Figure 7. Effect of Stereotaxic Administration of shVGLUT2 in the
LHA on BMP8B Action
(A–F) The (A) western blot images (left panel) and LHA VGLUT2 protein levels,
(B) body temperature change, (C) thermal images (left panel) and quantification
of temperature change of the skin surrounding BAT (right panel), (D) in situ
hybridization images (left panel) and OX mRNA levels in the LHA (right panel),
and (E and F) western blot images (left panels) and BAT UCP1 protein levels of
rats treated i.c.v. with vehicle or BMP8B and stereotaxically treated with GFP
or shVGLUT2 lentiviruses within the LHA. Data are expressed as mean ± SEM
(n = 6–9 animals per experimental group; *p < 0.05, **p < 0.01, and ***p < 0.001
versus GFP (A) or vehicle GFP (E); ##p < 0.01 and ###p < 0.001 versus BMP8B
GFP). Temperature changes were calculated versus basal values.In spite of this evidence, it was totally unclear whether AMPK in
the VMH andOX in the LHA are part of the same functional link or
they exert their thermogenic actions separately. Anatomical data
supported the hypothesis of an interconnected pathway,
because it was known that VMH efferents project to the LHA
and provide passing innervation on their way to their target areas
(Lindberg et al., 2013). To address that possibility, we investi-
gated the central thermogenic effect of BMP8B, which is associ-
ated with (1) decreased AMPK function in the VMH; (2) increased
activity in RPa, inferior olive (IO), and sympathetic tone; and (3)
neuronal activation within the LHA (Whittle et al., 2012). Our
data showed that administration of BMP8Bwithin the VMH reca-
pitulated the effect of its central (i.c.v.) administration (Whittle
et al., 2012), namely feeding-independent weight loss, increasedEE and BAT thermogenesis, and reduced RQ, in association with
reduced AMPK signaling in the VMH and elevated BAT UCP1
protein content as well as browning of WAT. None of these out-
comes was observed when BMP8B was specifically delivered
into the LHA, which excluded its direct effect at this level.
Interestingly, the thermogenic effect of both central and VMH-
specific BMP8B administration correlated with increased OX
expression in the LHA. Considering that OX also is known to
stimulate thermogenesis through the RPa-SNS route (Tupone
et al., 2011), we investigated its potential link with the BMP8B-
AMPK pathway. We observed that both the thermogenic effect
of BMP8B and the elevation of OXmRNA expression were totally
absent when BMP8B was given in combination with adenoviral
particles encoding AMPKa-CA, indicating that AMPK in the
VMH was acting upstream of OX neurons in the LHA. Impor-
tantly, the above effects were reversed by pharmacological
blockage of OX1R and were totally absent when BMP8B was
centrally delivered in OX KO mice, even in a cold environment,
which confirmed again AMPK’s upstream position in this
network.
To gain further insight into this central pathway, we investi-
gated the cellular mechanism regulating OX expression by
BMP8B. It is known that glutamate transporters, particularity
VGLUT2, are highly expressed in the hypothalamus, including
OX neurons (Ziegler et al., 2002; Rosin et al., 2003), and play a
main role in the regulation of energy balance (Tong et al.,
2007). Therefore, we hypothesized a possible link with BMP8B
effects on OX neurons in the LHA. To check that possibility, we
knocked down VGLUT2 in the LHA using lentiviruses harboring
an shRNA. Notably, VGLUT2 inhibition totally blunted BMP8B’s
effects on temperature, OX expression in the LHA, and UCP1
expression in BAT. Whether VGLUT2 in AMPK-expressing neu-
rons mediates this effect is unclear. However, it has been re-
vealed recently, by using conditional viral tracing, that SF1 neu-
rons, a major cell population inside the VMH, project and
terminate in the LHA (Lindberg et al., 2013), which may provide
an anatomical basis for the interaction of AMPK(VMH)-gluta-
mate-OX(LHA).
These results are of relevance for several reasons. First, they
uncover a physiological hypothalamic network governing energy
homeostasis, which might be of relevance for therapeutic ap-
proaches. In this sense, it is important to highlight that the orig-
inal theories explaining the central control of energy balance
were based on a Dual Centre Hypothesis (Hecherington and
Ranson, 1942; Anand and Brobeck, 1951). In that model, feeding
was controlled by two hypothalamic areas: the LHA hunger cen-
ter and the VMH satiety center. Lesions of the LHA decreased
food intake and eventually led to starvation and death.
Conversely, lesions of the VMH (and the neighboringmediobasal
area) resulted in obesity. The present results do not show an
impact on feeding, but this VMH (AMPK), glutamate and LHA
(OX) pathway provides the molecular basis for the interplay
and balance between these twomajor areas in the dynamic con-
trol of other key aspect of the energy balance equation, namely
EE. Second, the sexual dependency of the thermogenic effect
of BMP8B, and in particular the relevance of endogenous
ovarian steroids in the modulation of BMP8B thermogenic ac-
tions, might be of clinical relevance, considering the differentCell Reports 16, 2231–2242, August 23, 2016 2239
thermogenic adaptation observed in women and men (Palmer
and Clegg, 2015; Mauvais-Jarvis, 2015). Third, OXs are highly
pleiotropic peptides (Tsujino and Sakurai, 2009; Lo´pez et al.,
2010a; Gao and Horvath, 2014), one of their most important
functions being the regulation of arousal and sleep-wake cycle;
actually, the lack of OXs or impaired OXR signaling leads to
narcolepsy in several animal models (such as mice, rats, and
dogs) and humans (Chemelli et al., 1999; Lin et al., 1999; Nishino
et al., 2000; Gerashchenko et al., 2001). The fact that BMP8B
increased OX expression opens up the possibility that it may
have a potential role in the modulation of sleep patterns. We
did not address that possibility specifically, but our data show
that chronic treatment with BMP8B, specifically within the
VMH, tended to increase LA, which may be related to an in-
crease in the arousal state of the animals.
In summary, this study demonstrates that BMP8B modulates
energy homeostasis and, more precisely, thermogenesis, via
a well-defined hypothalamic pathway involving a VMH-LHA
interplay, and it uncovers a functional connection among
AMPK in the VMH, glutamatergic signaling, and OX in the LHA.
Our results show that two important brain mediators of BAT
thermogenesis act in a coordinate network. Whether this
mechanism is exclusive for BMP8B or it mediates the effect of
other thermogenic factors, such as leptin, thyroid hormones,
estradiol, glucagon-like peptide-1, or nicotine, is currently un-
known. However, considering that (1) all these factors share
the same VMH AMPK-SNS-BAT axis (Lo´pez et al., 2010b,
2016; Martı´nez de Morentin et al., 2012, 2014; Whittle et al.,
2012; Tanida et al., 2013; Beiroa et al., 2014; Contreras et al.,
2015), (2) some of them also modulate the neuronal activity in
RPa and IO (Lo´pez et al., 2010b; Martı´nez de Morentin et al.,
2014), and (3) some regulate OX expression (Lo´pez et al.,
2000; Kane et al., 2000; Porkka-Heiskanen et al., 2004; Pasu-
marthi et al., 2006), it is tempting to speculate that the
AMPK(VMH)-glutamate-OX(LHA)-SNS-BAT axis may be a ca-
nonical mechanism to regulate BAT metabolism, with patho-
physiological implications in obesity and metabolic disorders.
EXPERIMENTAL PROCEDURES
Animals
Adult female and male Sprague-Dawley rats (200–250 g, Animalario General
USC), adult female null Ox/Hcrt mice (orexin/hypocretin; B6.129S6-
Hcrttm1Ywa/J, 8–10 weeks old, The Jackson Laboratory), and their WT litter-
mates were used. The animals were housed with an artificial 12-hr light
(8:00 a.m. to 8:00 p.m.)/12-hr dark cycle, under controlled temperature
and humidity conditions, and they were allowed free access to standard lab-
oratory chow and tap water. During all experimental approaches, the animals
were monitored daily for food intake and body weight changes. The experi-
ments were performed in agreement with the International Law on Animal
Experimentation and were approved by the USC Ethical Committee (Project
ID 15010/14/006).
Experimental Models
Ovariectomy and estradiol replacement, i.c.v. and nucleus-specific treat-
ments, and stereotaxic microinjection of adenoviral and lentiviral vectors
were performed as described previously (Nogueiras et al., 2007; Lo´pez
et al., 2008, 2010b; Whittle et al., 2012; Martı´nez de Morentin et al., 2012,
2014, 2015; A´lvarez-Crespo et al., 2013; Imbernon et al., 2013; Contreras
et al., 2014; Beiroa et al., 2014; Folgueira et al., 2016). See the Supplemental
Experimental Procedures for detailed protocols.2240 Cell Reports 16, 2231–2242, August 23, 2016Sample Processing and Analytical Methods
Sample processing, EE, LA, RQ, and nuclear magnetic resonance (NMR)
analyses; temperature measurements; in situ hybridization; western blotting;
real-time PCR; and immunohistochemistry were performed as described pre-
viously (Lo´pez et al., 2008, 2010b; Whittle et al., 2012; Martı´nez de Morentin
et al., 2012, 2014; Varela et al., 2012; A´lvarez-Crespo et al., 2013; Contreras
et al., 2014; Beiroa et al., 2014; Folgueira et al., 2016). See the Supplemental
Experimental Procedures for detailed protocols.
Statistical Analysis
Data are expressed as mean ± SEM. The mRNA and protein data were ex-
pressed in relation (%) to control (vehicle-treated) rats. Error bars represent
SEM. Statistical significance was determined by Student’s t test when two
groups were compared or ANOVA and post hoc two-tailed Bonferroni test
when more than two groups were compared (p < 0.05 was considered
significant).
SUPPLEMENTAL INFORMATION
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three figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.07.045.
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